Brief: Synact Pharma Q2 Pre-Tax Loss Widens To SEK 9.9 Million
30/08/2018 09:47
Aug 30 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q2 PRE-TAX LOSS SEK 9.9 MILLION VERSUS LOSS SEK 5.2
MILLION YEAR
AGO
Source text for Eikon: ID:nNDL46K2X0
Further company coverage: SYNACT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026